CNR1 and myeloid sarcoma: As Cannabinoid-1-receptors (CB1R) are therapeutic targets for the treatment of various associated symptoms of MS, Kheirdah et al. [36] aimed to assess the impact of aerobic exercise and two doses of RJ on hippocampus CB1R and pain threshold (PT) in an EAE model.